RE:RE:Questionalleyesonme wrote: Labs Barrie facility, years past produced 30-50m$ quarterly wholesale sales ..capacity/ to produce isn't a factor, neither is wholesale bulk B2B cannabis procurement, this is how they operated prior to VIVO, and I'd imagine they still procure some flower for distillation....epidiolex sells between 1700$-2200usd which is a 100ml bottle of pure CBD oil covered by major insurers...between VIVO and LABs more than 800m has been spent...this is going to be a massive year....the U.S will approve the NDA, blockbuster, much bigger than epidiolex....trials are complete...all trials have been for aielments affecting many...much more than the rare cases of epilepsy that's generating a billion for JAZZ..p.s..Danno...I've been watching next leaf also...you read my mind.
thank you for the response to my qustion but I think the answer is somewhat superficial.
30-50 mill in wholesale sales in the past tells me nothing in regard to their ability to produce enough product of highly distilled pharma grade (for lack of a better tearm) CBD
yes with the purchase of ViVo they have some production of their own flower but if this hits as we expect it to that will not be enough to fullfill possible orders... i would think that you cant just use any kind of weed tp make the stuff we are talking about.
is there any Info on production capacity at the Barrie facility as this would be the only place they have FDA approval for and if an expansion is nesscessary the new place would have to be inspected and licensed
what about the answers to the other questions i posed... anyone?
before i start digging there may be someone who ha done some of the leg work and is willing to share?
and possibly not just ..dont worry they can do it its all right sort of answer
if you cant fullfill thye billion dollar orders then you cant become a billion $ company!...here is hoping!